Evidence map›Paper›PMID 42010348›Full record

ReviewCommunications medicine2026

Harnessing health economic evaluation for policy and practice.

Yot Teerawattananon, Yi Wang, Sarin Kc, Hugo C Turner, Benjamin Sk Ong, Wanrudee Isaranuwatchai

Abstract readReview
In one paragraph

Review in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yot TeerawattananonHealth Intervention and Technology Assessment Program Foundation, Ministry of Public Health, Nonthaburi, Thailand.ORCID http://orcid.org/0000-0003-2217-2930
Yi WangSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore. ephwyi@nus.edu.sg.ORCID http://orcid.org/0000-0003-1934-9926
Sarin KcHealth Intervention and Technology Assessment Program Foundation, Ministry of Public Health, Nonthaburi, Thailand.
Hugo C TurnerMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Benjamin Sk OngAgency for Care Effectiveness, Ministry of Health, Singapore, Singapore.
Wanrudee IsaranuwatchaiHealth Intervention and Technology Assessment Program Foundation, Ministry of Public Health, Nonthaburi, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health economic evaluation is essential for evidence-informed health policy, supporting prioritization of high-value care and optimal resource use. This Perspective synthesizes experiences from the HTAsiaLink network and global literature to demonstrate its role across the technology lifecycle. Drawing on diverse country experiences, it highlights how these methods guide value-based, equitable, and sustainable decision-making amid rapid technological advances and resources constraints. Key challenges and opportunities are examined, such as integrating equity considerations, incorporation of environmental impacts, and adapting frameworks for novel technologies. Strengthening deliberative processes, building capacity, and adopting flexible methods are crucial to harnessing full potential of health economic evaluation.

Identifiers

PMID42010348
PMCPMC13096234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.